List of Tables
Table 1. Global Non-recombinant Coagulation Factors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Non-recombinant Coagulation Factors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Non-recombinant Coagulation Factors Market Competitive Situation by Manufacturers in 2024
Table 4. Global Non-recombinant Coagulation Factors Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Non-recombinant Coagulation Factors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Non-recombinant Coagulation Factors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Non-recombinant Coagulation Factors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Non-recombinant Coagulation Factors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Non-recombinant Coagulation Factors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Non-recombinant Coagulation Factors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-recombinant Coagulation Factors, Product Type & Application
Table 12. Global Key Manufacturers of Non-recombinant Coagulation Factors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-recombinant Coagulation Factors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-recombinant Coagulation Factors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-recombinant Coagulation Factors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Non-recombinant Coagulation Factors Sales by Region (2020-2025) & (K Units)
Table 18. Global Non-recombinant Coagulation Factors Sales Market Share by Region (2020-2025)
Table 19. Global Non-recombinant Coagulation Factors Sales by Region (2026-2031) & (K Units)
Table 20. Global Non-recombinant Coagulation Factors Sales Market Share by Region (2026-2031)
Table 21. Global Non-recombinant Coagulation Factors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Non-recombinant Coagulation Factors Revenue Market Share by Region (2020-2025)
Table 23. Global Non-recombinant Coagulation Factors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Non-recombinant Coagulation Factors Revenue Market Share by Region (2026-2031)
Table 25. North America Non-recombinant Coagulation Factors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Non-recombinant Coagulation Factors Sales by Country (2020-2025) & (K Units)
Table 27. North America Non-recombinant Coagulation Factors Sales by Country (2026-2031) & (K Units)
Table 28. North America Non-recombinant Coagulation Factors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Non-recombinant Coagulation Factors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Non-recombinant Coagulation Factors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Non-recombinant Coagulation Factors Sales by Country (2020-2025) & (K Units)
Table 32. Europe Non-recombinant Coagulation Factors Sales by Country (2026-2031) & (K Units)
Table 33. Europe Non-recombinant Coagulation Factors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Non-recombinant Coagulation Factors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Non-recombinant Coagulation Factors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Non-recombinant Coagulation Factors Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Non-recombinant Coagulation Factors Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Non-recombinant Coagulation Factors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Non-recombinant Coagulation Factors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Non-recombinant Coagulation Factors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Non-recombinant Coagulation Factors Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Non-recombinant Coagulation Factors Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Non-recombinant Coagulation Factors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Non-recombinant Coagulation Factors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Non-recombinant Coagulation Factors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Non-recombinant Coagulation Factors Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Non-recombinant Coagulation Factors Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Non-recombinant Coagulation Factors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Non-recombinant Coagulation Factors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Non-recombinant Coagulation Factors Sales (K Units) by Type (2020-2025)
Table 51. Global Non-recombinant Coagulation Factors Sales (K Units) by Type (2026-2031)
Table 52. Global Non-recombinant Coagulation Factors Sales Market Share by Type (2020-2025)
Table 53. Global Non-recombinant Coagulation Factors Sales Market Share by Type (2026-2031)
Table 54. Global Non-recombinant Coagulation Factors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Non-recombinant Coagulation Factors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Non-recombinant Coagulation Factors Revenue Market Share by Type (2020-2025)
Table 57. Global Non-recombinant Coagulation Factors Revenue Market Share by Type (2026-2031)
Table 58. Global Non-recombinant Coagulation Factors Price (US$/Unit) by Type (2020-2025)
Table 59. Global Non-recombinant Coagulation Factors Price (US$/Unit) by Type (2026-2031)
Table 60. Global Non-recombinant Coagulation Factors Sales (K Units) by Application (2020-2025)
Table 61. Global Non-recombinant Coagulation Factors Sales (K Units) by Application (2026-2031)
Table 62. Global Non-recombinant Coagulation Factors Sales Market Share by Application (2020-2025)
Table 63. Global Non-recombinant Coagulation Factors Sales Market Share by Application (2026-2031)
Table 64. Global Non-recombinant Coagulation Factors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Non-recombinant Coagulation Factors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Non-recombinant Coagulation Factors Revenue Market Share by Application (2020-2025)
Table 67. Global Non-recombinant Coagulation Factors Revenue Market Share by Application (2026-2031)
Table 68. Global Non-recombinant Coagulation Factors Price (US$/Unit) by Application (2020-2025)
Table 69. Global Non-recombinant Coagulation Factors Price (US$/Unit) by Application (2026-2031)
Table 70. Takeda Pharmaceutical Company Information
Table 71. Takeda Pharmaceutical Description and Business Overview
Table 72. Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Takeda Pharmaceutical Non-recombinant Coagulation Factors Product
Table 74. Takeda Pharmaceutical Recent Developments/Updates
Table 75. Instituto Grifols SA Company Information
Table 76. Instituto Grifols SA Description and Business Overview
Table 77. Instituto Grifols SA Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Instituto Grifols SA Non-recombinant Coagulation Factors Product
Table 79. Instituto Grifols SA Recent Developments/Updates
Table 80. CSL Behring LLC Company Information
Table 81. CSL Behring LLC Description and Business Overview
Table 82. CSL Behring LLC Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. CSL Behring LLC Non-recombinant Coagulation Factors Product
Table 84. CSL Behring LLC Recent Developments/Updates
Table 85. KM Biologics KK Company Information
Table 86. KM Biologics KK Description and Business Overview
Table 87. KM Biologics KK Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. KM Biologics KK Non-recombinant Coagulation Factors Product
Table 89. KM Biologics KK Recent Developments/Updates
Table 90. Baxter Healthcare Corp. Company Information
Table 91. Baxter Healthcare Corp. Description and Business Overview
Table 92. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product
Table 94. Baxter Healthcare Corp. Recent Developments/Updates
Table 95. Sanquin Company Information
Table 96. Sanquin Description and Business Overview
Table 97. Sanquin Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Sanquin Non-recombinant Coagulation Factors Product
Table 99. Sanquin Recent Developments/Updates
Table 100. Johnson & Johnson Company Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Johnson & Johnson Non-recombinant Coagulation Factors Product
Table 104. Johnson & Johnson Recent Developments/Updates
Table 105. Octapharma AG Company Information
Table 106. Octapharma AG Description and Business Overview
Table 107. Octapharma AG Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Octapharma AG Non-recombinant Coagulation Factors Product
Table 109. Octapharma AG Recent Developments/Updates
Table 110. Bio Products Laboratory Ltd. Company Information
Table 111. Bio Products Laboratory Ltd. Description and Business Overview
Table 112. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product
Table 114. Bio Products Laboratory Ltd. Recent Developments/Updates
Table 115. Grifols Biologicals, Inc. Company Information
Table 116. Grifols Biologicals, Inc. Description and Business Overview
Table 117. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product
Table 119. Grifols Biologicals, Inc. Recent Developments/Updates
Table 120. Pfizer Inc. Company Information
Table 121. Pfizer Inc. Description and Business Overview
Table 122. Pfizer Inc. Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Pfizer Inc. Non-recombinant Coagulation Factors Product
Table 124. Pfizer Inc. Recent Developments/Updates
Table 125. Intas Biopharmaceuticals Ltd. Company Information
Table 126. Intas Biopharmaceuticals Ltd. Description and Business Overview
Table 127. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product
Table 129. Intas Biopharmaceuticals Ltd. Recent Developments/Updates
Table 130. Shandong Taibang Biological Products Company Information
Table 131. Shandong Taibang Biological Products Description and Business Overview
Table 132. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product
Table 134. Shandong Taibang Biological Products Recent Developments/Updates
Table 135. Sinopharm Group Shanghai Blood Products Company Information
Table 136. Sinopharm Group Shanghai Blood Products Description and Business Overview
Table 137. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product
Table 139. Sinopharm Group Shanghai Blood Products Recent Developments/Updates
Table 140. SHANGHAI RAAS Company Information
Table 141. SHANGHAI RAAS Description and Business Overview
Table 142. SHANGHAI RAAS Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. SHANGHAI RAAS Non-recombinant Coagulation Factors Product
Table 144. SHANGHAI RAAS Recent Developments/Updates
Table 145. China Resources Boya Bio-Pharmaceutical Company Information
Table 146. China Resources Boya Bio-Pharmaceutical Description and Business Overview
Table 147. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product
Table 149. China Resources Boya Bio-Pharmaceutical Recent Developments/Updates
Table 150. Chengdu Rongsheng Pharmaceuticals Company Information
Table 151. Chengdu Rongsheng Pharmaceuticals Description and Business Overview
Table 152. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product
Table 154. Chengdu Rongsheng Pharmaceuticals Recent Developments/Updates
Table 155. Yuanda Shuyang Pharmaceutical Company Information
Table 156. Yuanda Shuyang Pharmaceutical Description and Business Overview
Table 157. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product
Table 159. Yuanda Shuyang Pharmaceutical Recent Developments/Updates
Table 160. HUALAN BIO Company Information
Table 161. HUALAN BIO Description and Business Overview
Table 162. HUALAN BIO Non-recombinant Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. HUALAN BIO Non-recombinant Coagulation Factors Product
Table 164. HUALAN BIO Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Non-recombinant Coagulation Factors Distributors List
Table 168. Non-recombinant Coagulation Factors Customers List
Table 169. Non-recombinant Coagulation Factors Market Trends
Table 170. Non-recombinant Coagulation Factors Market Drivers
Table 171. Non-recombinant Coagulation Factors Market Challenges
Table 172. Non-recombinant Coagulation Factors Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non-recombinant Coagulation Factors
Figure 2. Global Non-recombinant Coagulation Factors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non-recombinant Coagulation Factors Market Share by Type: 2024 & 2031
Figure 4. Coagulation Factor VIII Product Picture
Figure 5. Human Fibrinogen Product Picture
Figure 6. Others Product Picture
Figure 7. Global Non-recombinant Coagulation Factors Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Non-recombinant Coagulation Factors Market Share by Application: 2024 & 2031
Figure 9. Hemophilia
Figure 10. Fibrinogen Deficiency
Figure 11. Other
Figure 12. Global Non-recombinant Coagulation Factors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Non-recombinant Coagulation Factors Market Size (2020-2031) & (US$ Million)
Figure 14. Global Non-recombinant Coagulation Factors Sales (2020-2031) & (K Units)
Figure 15. Global Non-recombinant Coagulation Factors Average Price (US$/Unit) & (2020-2031)
Figure 16. Non-recombinant Coagulation Factors Report Years Considered
Figure 17. Non-recombinant Coagulation Factors Sales Share by Manufacturers in 2024
Figure 18. Global Non-recombinant Coagulation Factors Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Non-recombinant Coagulation Factors Players: Market Share by Revenue in Non-recombinant Coagulation Factors in 2024
Figure 20. Non-recombinant Coagulation Factors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Non-recombinant Coagulation Factors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Non-recombinant Coagulation Factors Sales Market Share by Country (2020-2031)
Figure 23. North America Non-recombinant Coagulation Factors Revenue Market Share by Country (2020-2031)
Figure 24. United States Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Non-recombinant Coagulation Factors Sales Market Share by Country (2020-2031)
Figure 27. Europe Non-recombinant Coagulation Factors Revenue Market Share by Country (2020-2031)
Figure 28. Germany Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Non-recombinant Coagulation Factors Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Non-recombinant Coagulation Factors Revenue Market Share by Region (2020-2031)
Figure 35. China Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Non-recombinant Coagulation Factors Sales Market Share by Country (2020-2031)
Figure 43. Latin America Non-recombinant Coagulation Factors Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Non-recombinant Coagulation Factors Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Non-recombinant Coagulation Factors Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Non-recombinant Coagulation Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Non-recombinant Coagulation Factors by Type (2020-2031)
Figure 53. Global Revenue Market Share of Non-recombinant Coagulation Factors by Type (2020-2031)
Figure 54. Global Non-recombinant Coagulation Factors Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Non-recombinant Coagulation Factors by Application (2020-2031)
Figure 56. Global Revenue Market Share of Non-recombinant Coagulation Factors by Application (2020-2031)
Figure 57. Global Non-recombinant Coagulation Factors Price (US$/Unit) by Application (2020-2031)
Figure 58. Non-recombinant Coagulation Factors Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
